PQM130, a Novel Feruloyl–Donepezil Hybrid Compound, Effectively Ameliorates the Cognitive Impairments and Pathology in a Mouse Model of Alzheimer’s Disease

Abstract

Alzheimer’s disease (AD) is the most frequent type of dementia in older people. The complex nature of AD calls for the development of multitarget agents addressing key pathogenic processes. Donepezil, an acetylcholinesterase inhibitor, is a first-line acetylcholinesterase inhibitor used for the treatment of AD. Although several studies have demonstrated the symptomatic efficacy of donepezil treatment in AD patients, the possible effects of donepezil on the AD process are not yet known. In this study, a novel feruloyl–donepezil hybrid compound (PQM130) was synthesized and evaluated as a multitarget drug candidate against the neurotoxicity induced by Aβ 1-42 oligomer (AβO) injection in mice. Interestingly, PQM130 had already shown anti-inflammatory activity in different in vivo models and neuroprotective activity in human neuronal cells. The intracerebroventricular (i.c.v.) injection of AβO in mice caused the increase of memory impairment, oxidative stress, neurodegeneration, and neuroinflammation. Instead, PQM130 (0.5–1 mg/kg) treatment after the i.c.v. AβO injection reduced oxidative damage and neuroinflammation and induced cell survival and protein synthesis through the modulation of glycogen synthase kinase 3β (GSK3β) and extracellular signal–regulated kinases (ERK1/2). Moreover, PQM130 increased brain plasticity and protected mice against the decline in spatial cognition. Even more interesting is that PQM130 modulated different pathways compared to donepezil, and it is much more effective in counteracting AβO damage. Therefore, our findings highlighted that PQM130 is a potent multi-functional agent against AD and could act as a promising neuroprotective compound for anti-AD drug development.

Quercetin‐3‐O‐Glucuronide Alleviates Cognitive Deficit and Toxicity in Aβ1‐42‐Induced AD‐Like Mice and SH‐SY5Y Cells

“…[58] F. Morroni et al found A 1-42 injection affected AKT and MAPK. [59] Motivated by these researches, we tested the downstream proteins in insulin signaling in the present study. It turned out that abnormal insulin signaling in the hippocampus was observed in A group, as evidenced by both phosphorylation of AKT and MAPK reduced in A -induced mice.…”

Curcumin in Health and Diseases: Alzheimer’s Disease and Curcumin Analogues, Derivatives, and Hybrids

“…In vitro possibility to pass BBB [69] Feruloyl-donepezil hybrid ability to modify the kinetics of Aβ fibril formation…”

“…Morroni et al [69] studied a novel feruloyl-donepezil hybrid compound AB78. The researchers prepared this compound and tested it as a multitarget agentfor the treatmentof neurotoxicity induced by the administration of Aβ 1-42 oligomer (AβO) in mice.…”

Common Protective Strategies in Neurodegenerative Disease: Focusing on Risk Factors to Target the Cellular Redox System

“…The fundamental role of oxidative stress in neurodegenerative disorders is recognized, and, also in the early stages, it is possible to observe a significant increase of ROS production [55]. When this phenomenon is efficiently reduced, also the cognitive impairment and the inflammatory processes are successfully counteracted [56,57]. Indeed, there is a close relationship among oxidative stress, aging, and inflammation.…”